Ramesha H. Jayaramaiah, Eleonora Egidi, Catriona A. Macdonald, Jun-Tao Wang, Thomas C. Jeffries, Mallavarapu Megharaj, Brajesh K. Singh
Understanding the relative importance of soil microbial diversity, plants and nutrient management is crucial to implement an effective bioremediation approach to xenobiotics-contaminated soils. To date, knowledge on the interactive effects of soil microbiome, plant and nutrient supply on influencing biodegradation potential of soils remains limited. In this study, we evaluated the individual and interactive effects of soil initial bacterial diversity, nutrient amendments (organic and inorganic) and plant presence on the biodegradation rate of pyrene, a polycyclic aromatic hydrocarbon. Initial bacterial diversity had a strong positive impact on soil biodegradation potential, with soil harbouring higher bacterial diversity showing ~ 2 times higher degradation rates than soils with lower bacterial diversity. Both organic and inorganic nutrient amendments consistently improved the degradation rate in lower diversity soils and had negative (inorganic) to neutral (organic) effect in higher diversity soils. Interestingly, plant presence/type did not show any significant effect on the degradation rate in most of the treatments. Structural equation modelling demonstrated that initial bacterial diversity had a prominent role in driving pyrene biodegradation rates. We provide novel evidence that suggests that soil initial microbial diversity, and nutrient amendments should be explicitly considered in the design and employment of bioremediation management strategies for restoring natural habitats disturbed by organic pollutants.
{"title":"Soil initial bacterial diversity and nutrient availability determine the rate of xenobiotic biodegradation","authors":"Ramesha H. Jayaramaiah, Eleonora Egidi, Catriona A. Macdonald, Jun-Tao Wang, Thomas C. Jeffries, Mallavarapu Megharaj, Brajesh K. Singh","doi":"10.1111/1751-7915.13946","DOIUrl":"https://doi.org/10.1111/1751-7915.13946","url":null,"abstract":"<p>Understanding the relative importance of soil microbial diversity, plants and nutrient management is crucial to implement an effective bioremediation approach to xenobiotics-contaminated soils. To date, knowledge on the interactive effects of soil microbiome, plant and nutrient supply on influencing biodegradation potential of soils remains limited. In this study, we evaluated the individual and interactive effects of soil initial bacterial diversity, nutrient amendments (organic and inorganic) and plant presence on the biodegradation rate of pyrene, a polycyclic aromatic hydrocarbon. Initial bacterial diversity had a strong positive impact on soil biodegradation potential, with soil harbouring higher bacterial diversity showing ~ 2 times higher degradation rates than soils with lower bacterial diversity. Both organic and inorganic nutrient amendments consistently improved the degradation rate in lower diversity soils and had negative (inorganic) to neutral (organic) effect in higher diversity soils. Interestingly, plant presence/type did not show any significant effect on the degradation rate in most of the treatments. Structural equation modelling demonstrated that initial bacterial diversity had a prominent role in driving pyrene biodegradation rates. We provide novel evidence that suggests that soil initial microbial diversity, and nutrient amendments should be explicitly considered in the design and employment of bioremediation management strategies for restoring natural habitats disturbed by organic pollutants.</p>","PeriodicalId":49145,"journal":{"name":"Microbial Biotechnology","volume":"15 1","pages":"318-336"},"PeriodicalIF":5.7,"publicationDate":"2021-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sfamjournals.onlinelibrary.wiley.com/doi/epdf/10.1111/1751-7915.13946","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"6028850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yuanzhe Li, Yang Liu, Bingqing Yao, Srikanth Narasimalu, ZhiLi Dong
The recent COVID-19 virus has led to a rising interest in antimicrobial and antiviral coatings for frequently touched surfaces in public and healthcare settings. Such coatings may have the ability to kill a variety of microorganisms and bio-structures and reduce the risk of virus transmission. This paper proposes an extremely rapid method to introduce rare-earth doping nano-ZnO in polyamines for the preparation of the anti-microbial polyurea coatings. The nano-ZnO is prepared by wet chemical method, and the RE-doped nano-ZnO was obtained by mixing nano ZnO and RE-dopants with an appropriate amount of nitric acid. This rapidly fabricated polyurea coating can effectively reduce bacteria from enriching on the surface. Comparing with pure nano-ZnO group, all the polyurea coatings with four different rare-earth elements (La, Ce, Pr and Gd) doped nano-ZnO. The La-doped nano-ZnO formula group indicates the highest bactericidal rate over 85% to Escherichia coli (E. coli) and Pseudomonas aeruginosa (Pseudomonas). Followed by Ce/ZnO, the bactericidal rate may still remain as high as 83% at room temperature after 25-min UV-exposure. It is believed that the RE-doping process may greatly improve the photocatalytic response to UV light as well as environmental temperature due to its thermal catalytic enhancement. Through the surface characterizations and bioassays, the coatings have a durably high bactericidal rate even after repeated usage. As polyurea coating itself has high mechanical strength and adhesive force with most substrate materials without peel-off found, this rapid preparation method will also provide good prospects in practical applications.
{"title":"Rapid preparation and antimicrobial activity of polyurea coatings with RE-Doped nano-ZnO","authors":"Yuanzhe Li, Yang Liu, Bingqing Yao, Srikanth Narasimalu, ZhiLi Dong","doi":"10.1111/1751-7915.13891","DOIUrl":"https://doi.org/10.1111/1751-7915.13891","url":null,"abstract":"<p>The recent COVID-19 virus has led to a rising interest in antimicrobial and antiviral coatings for frequently touched surfaces in public and healthcare settings. Such coatings may have the ability to kill a variety of microorganisms and bio-structures and reduce the risk of virus transmission. This paper proposes an extremely rapid method to introduce rare-earth doping nano-ZnO in polyamines for the preparation of the anti-microbial polyurea coatings. The nano-ZnO is prepared by wet chemical method, and the RE-doped nano-ZnO was obtained by mixing nano ZnO and RE-dopants with an appropriate amount of nitric acid. This rapidly fabricated polyurea coating can effectively reduce bacteria from enriching on the surface. Comparing with pure nano-ZnO group, all the polyurea coatings with four different rare-earth elements (La, Ce, Pr and Gd) doped nano-ZnO. The La-doped nano-ZnO formula group indicates the highest bactericidal rate over 85% to <i>Escherichia coli</i> (<i>E</i>. <i>coli)</i> and <i>Pseudomonas aeruginosa</i> (<i>Pseudomonas</i>). Followed by Ce/ZnO, the bactericidal rate may still remain as high as 83% at room temperature after 25-min UV-exposure. It is believed that the RE-doping process may greatly improve the photocatalytic response to UV light as well as environmental temperature due to its thermal catalytic enhancement. Through the surface characterizations and bioassays, the coatings have a durably high bactericidal rate even after repeated usage. As polyurea coating itself has high mechanical strength and adhesive force with most substrate materials without peel-off found, this rapid preparation method will also provide good prospects in practical applications.</p>","PeriodicalId":49145,"journal":{"name":"Microbial Biotechnology","volume":"15 2","pages":"548-560"},"PeriodicalIF":5.7,"publicationDate":"2021-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sfamjournals.onlinelibrary.wiley.com/doi/epdf/10.1111/1751-7915.13891","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"5755466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
<p>In the early 1900s, German chemist, Paul Ehrlich commenced developing drugs to treat infectious diseases and coined the term ‘chemotherapy’ defining it as the use of chemicals to treat disease. He developed the first alkylating agents, to treat cancer.</p><p>While some spectacular cures were observed with each of these approaches, most patients experienced tumour relapse and eventually succumbed to the disease. These advances provided an incremental advance in the treatment of cancer and almost all of them were associated with moderate to severe toxicity. Throughout this time, there was a major effort to discover antigens that were tumour-specific with a hope that tumour-targeted therapies could be developed with minimal toxicity to normal tissues. This effort has yet to bear fruit.</p><p>This issue focuses the mind on taking a step back and learning from history, getting to the roots of the problem and deciphering if there is a better way to address it so that we are able to pursue a more realistic path in the decade to come.</p><p>Interestingly, microbial cells may offer solutions to these seemingly insurmountable problems.</p><p>Given that most cancer cells elaborate a sophisticated plethora of drug resistance and immune-suppressive mechanisms, is there any way to overcome multi-drug resistance in cancer cells? Going after each different drug resistance mechanism or individual targets would again lead to hundreds of drugs with attendant toxicities and appropriate therapy would be impossible. Additionally, experience shows that targeting just one or two pathways can be easily overcome by tumour cells since they elaborate a multitude of different drug resistance pathways which can overcome single hits.</p><p>It is known for some time that there are cytotoxic drugs that can overcome multiple drug resistance mechanisms simply by virtue of the fact that these drugs are super-poisons. Examples include (i) PNU-159682, a metabolite of the anthracycline nemorubicin, a highly potent DNA topoisomerase I inhibitor which is over 2000-fold more toxic than conventional drug doxorubicin, (ii) Duocarmycin which is a DNA minor groove-binding alkylating agent, (iii) Maytansine, a benzoansamacrolide, a highly potent microtubule-targeted compound that induces mitotic arrest and kills tumour cells at sub-nanomolar concentrations etc. Unfortunately, these drugs cannot be administered in patients as free chemotherapy since they are too toxic and would kill a person due to rapid and widespread killing of normal cells. These drugs are being developed as antibody-drug conjugates but even then, they are seriously toxic in patients.</p><p>If it were possible to safely administer these drugs into cancer patients so that the drug is specifically taken up inside cancer cells and not normal cells, then it should be possible to kill even the most drug-resistant cancer cells. Bacterial minicells which are anucleate nanoparticles produced as a result of inactivating the genes
20世纪初,德国化学家保罗·埃利希开始开发治疗传染病的药物,并创造了“化疗”一词,将其定义为使用化学物质治疗疾病。他发明了第一种烷基化剂,用于治疗癌症。虽然每一种方法都有一些惊人的疗效,但大多数患者都经历了肿瘤复发,最终死于这种疾病。这些进展为癌症治疗提供了一个渐进的进展,几乎所有这些进展都与中度到重度毒性有关。在这段时间里,人们一直在努力发现肿瘤特异性抗原,希望能够开发出对正常组织毒性最小的肿瘤靶向治疗方法。这一努力尚未取得成果。这个问题需要我们从历史中吸取教训,从问题的根源上找出解决问题的更好办法,以便在未来十年走一条更现实的道路。有趣的是,微生物细胞可能为这些看似无法克服的问题提供解决方案。考虑到大多数癌细胞精心设计了复杂的过多的耐药性和免疫抑制机制,有没有办法克服癌细胞的多重耐药性?追踪每一种不同的耐药机制或单个靶点将再次导致数百种药物伴随毒性,而适当的治疗将是不可能的。此外,经验表明,仅针对一两个途径可以很容易地被肿瘤细胞克服,因为它们精心设计了许多不同的耐药途径,可以克服单一的打击。一段时间以来,我们知道有一些细胞毒性药物可以克服多重耐药机制,仅仅是因为这些药物是超级毒药。例子包括(i) pnu159682,一种蒽环类奈莫比星的代谢物,一种高效的DNA拓扑异构酶i抑制剂,其毒性比传统药物多柔比星高2000倍;(ii)多卡霉素,一种DNA微小凹槽结合烷基化剂;(iii)美坦辛,一种苯甲ansamacrolide,一种高效的微管靶向化合物,可诱导有丝分裂停止并在亚纳摩尔浓度下杀死肿瘤细胞等。不幸的是,这些药物不能作为免费的化疗药物给病人使用,因为它们毒性太大,而且会迅速而广泛地杀死正常细胞,从而杀死一个人。这些药物是作为抗体-药物结合物开发的,但即使这样,它们对患者也有严重的毒性。如果有可能安全地将这些药物注射到癌症患者体内,这样药物就会被癌细胞而不是正常细胞吸收,那么就有可能杀死甚至是最耐药的癌细胞。细菌微型细胞是由于控制正常细菌细胞分裂的基因失活而产生的无核纳米颗粒(de Boer和Crossley, 1989;Lutkenhaus and Addinall, 1997;Ma和King, 2004),从而抑制细胞裂变的极性位点,可能为这些和其他细胞毒性药物递送障碍提供解决方案。从肠道沙门氏菌血清型鼠伤寒沙门氏菌(S. Typhimurium)中产生基因定义的minCDE-染色体缺失突变(MacDiarmid et al., 2007, 2009)。微型电池的直径为400纳米(因此在这里称为纳米电池或EDV™;基因梦想载体),无核的,无生命的,携带着包围着一个空细胞质的内外膜。研究表明,EDV可以很容易地包装一系列不同的细胞毒性药物或核酸,包括上述的超级毒物,有趣的是,一旦包装在细胞质中,药物就不会从EDV中泄漏出来,这一点在170多名晚期癌症患者的I期和ii期临床试验(正在进行中)中得到了证明,这些患者接受了超过2400剂量的携带不同细胞毒性药物的EDV (Kao等人,2015;Solomon et al., 2015;van Zandwijk et al., 2017;Sagnella et al., 2020)。尽管多次静脉注射(i.v.)给药,但这些患者几乎没有毒性,许多患者接受15至70次重复给药。考虑到EDV表面被脂多糖(LPS)包裹,单链双特异性抗体附着在EDV表面,其中抗体的一条手臂指向o -多糖表位,另一条手臂指向肿瘤细胞表面受体,例如表皮生长因子受体(EGFR),该受体存在于超过70%的实体肿瘤表面。药物包装的抗体靶向edv可以很容易地以高产量生产,并且使用药物交叉流和终端过滤器纯化不含亲代细菌、膜泡、核酸、细胞碎片和游离内毒素。最终的治疗方法是冻干,并在4°C下储存和运输到世界任何地方。 这些小瓶储存在医院药房,当病人要给药时,加入2毫升无菌注射用水来重建edv。靶向egfr、pnu包装的edv被静脉注射,由于其相对较大的尺寸(直径约400纳米),由于血管内皮细胞之间的间隙小于2纳米,它们被保留在正常的血液循环中。然而,众所周知,癌细胞的生长和转移需要进入血管,因此它们过度表达促血管生成因子,导致无序血管网络的发展,这与正常的血管系统根本不同。肿瘤血管系统的典型特征是异常的结构动力学和不成熟和高渗透性的血管(Siemann, 2011)。这些血管的开孔范围从20纳米到超过4 μm (Hashizume et al., 2000)。400纳米的EDV迅速从这些孔中脱落并进入肿瘤微环境,由于它们在EDV表面携带双特异性抗体,抗EGFR成分与肿瘤细胞表面的EGFR结合。这引起巨量红细胞增多症,edv被带入早期内体,随后进入溶酶体,并在这些细胞器中分解,释放药物PNU-159682。药物进入肿瘤细胞的细胞质和细胞核,与染色体DNA穿插,导致肿瘤细胞凋亡。如果一种肿瘤类型不表达EGFR,例如肝癌,它表达asialal糖蛋白,那么双特异性抗体可以改变为抗asialal糖蛋白,而抗o -多糖成分保持不变。同样,HER-2阳性乳腺癌也可以通过抗her2 /抗o -多糖双特异性抗体靶向治疗。这是超细胞毒性药物首次在没有毒性的情况下用于人类癌症患者。EDV的双膜结构阻止了药物在一般循环中的泄漏,EDV的大尺寸允许它避开被正常密封血管包围的正常组织,肿瘤相关的渗漏血管允许EDV进入肿瘤微环境,靶向EDV的双特异性抗体允许它特异性地进入肿瘤细胞,溶酶体降解机制允许EDV在细胞内被分解并释放出可以克服耐药性的药物,并首次杀死高度耐药的肿瘤细胞而没有毒性。到目前为止,所有接受治疗的170名癌症患者都是已经用尽所有治疗方案的晚期姑息治疗患者。在间皮瘤(Kao et al., 2015)、胶质母细胞瘤和胰腺癌(Sagnella et al., 2020)中观察到非常显著的抗肿瘤疗效。鉴于人体自身的免疫系统具有增强抗肿瘤功效的潜力,如果能够同时利用这种潜力而不产生与当前免疫疗法相关的毒性,那将是理想的。在一般血液循环中,尚未进入肿瘤微环境的edv,通过病原体相关分子模式(PAMPS),如LPS,被专业吞噬细胞(APCs),即存在于淋巴结、肝脏和脾脏中的巨噬细胞和树突状细胞(DCs)迅速识别为外来细胞。对PAMPS的识别导致apc释放像ATP一样的“警报信号”(Matzinger, 1994),这些信号被骨髓中静止的单核细胞接收。这些细胞随后被激活,经历成熟和增殖,并释放M1(杀肿瘤)巨噬细胞和活化的dc进入循环。与此同时,肿瘤微环境中垂死的肿瘤细胞(由于edv在细胞内释放细胞毒性药物)释放“寻找我”信号,如低水平的核苷酸ATP和UTP、fractalkine、溶血磷脂酰胆碱或鞘氨醇1-磷酸,这些信号将apc吸引到组织内的死亡部位(Gregory, 2009)。凋亡细胞在细胞表面暴露“吃我”信号,如钙网蛋白、磷脂酰丝氨酸,促进APC的特异性识别,随后将死亡细胞内化(Grimsley和Ravichandran, 2003)。凋亡的肿瘤细胞在细胞内降解,释放的蛋白抗原通过MHC I类和II类分子加工呈递到细胞表面。然后,这些apc迁移到引流淋巴结,在那里它们将肿瘤抗原呈递给CD4+和CD8+ T
{"title":"Bacterial minicells to the rescue: cyto-Immunotherapy for the treatment of late stage cancers with minimal to no toxicity","authors":"Himanshu Brahmbhatt, Jennifer A. MacDiarmid","doi":"10.1111/1751-7915.13952","DOIUrl":"https://doi.org/10.1111/1751-7915.13952","url":null,"abstract":"<p>In the early 1900s, German chemist, Paul Ehrlich commenced developing drugs to treat infectious diseases and coined the term ‘chemotherapy’ defining it as the use of chemicals to treat disease. He developed the first alkylating agents, to treat cancer.</p><p>While some spectacular cures were observed with each of these approaches, most patients experienced tumour relapse and eventually succumbed to the disease. These advances provided an incremental advance in the treatment of cancer and almost all of them were associated with moderate to severe toxicity. Throughout this time, there was a major effort to discover antigens that were tumour-specific with a hope that tumour-targeted therapies could be developed with minimal toxicity to normal tissues. This effort has yet to bear fruit.</p><p>This issue focuses the mind on taking a step back and learning from history, getting to the roots of the problem and deciphering if there is a better way to address it so that we are able to pursue a more realistic path in the decade to come.</p><p>Interestingly, microbial cells may offer solutions to these seemingly insurmountable problems.</p><p>Given that most cancer cells elaborate a sophisticated plethora of drug resistance and immune-suppressive mechanisms, is there any way to overcome multi-drug resistance in cancer cells? Going after each different drug resistance mechanism or individual targets would again lead to hundreds of drugs with attendant toxicities and appropriate therapy would be impossible. Additionally, experience shows that targeting just one or two pathways can be easily overcome by tumour cells since they elaborate a multitude of different drug resistance pathways which can overcome single hits.</p><p>It is known for some time that there are cytotoxic drugs that can overcome multiple drug resistance mechanisms simply by virtue of the fact that these drugs are super-poisons. Examples include (i) PNU-159682, a metabolite of the anthracycline nemorubicin, a highly potent DNA topoisomerase I inhibitor which is over 2000-fold more toxic than conventional drug doxorubicin, (ii) Duocarmycin which is a DNA minor groove-binding alkylating agent, (iii) Maytansine, a benzoansamacrolide, a highly potent microtubule-targeted compound that induces mitotic arrest and kills tumour cells at sub-nanomolar concentrations etc. Unfortunately, these drugs cannot be administered in patients as free chemotherapy since they are too toxic and would kill a person due to rapid and widespread killing of normal cells. These drugs are being developed as antibody-drug conjugates but even then, they are seriously toxic in patients.</p><p>If it were possible to safely administer these drugs into cancer patients so that the drug is specifically taken up inside cancer cells and not normal cells, then it should be possible to kill even the most drug-resistant cancer cells. Bacterial minicells which are anucleate nanoparticles produced as a result of inactivating the genes","PeriodicalId":49145,"journal":{"name":"Microbial Biotechnology","volume":"15 1","pages":"91-94"},"PeriodicalIF":5.7,"publicationDate":"2021-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1751-7915.13952","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"5734276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Eveline-Marie Lammens, Maarten Boon, Dennis Grimon, Yves Briers, Rob Lavigne
To meet the needs of synthetic biologists, DNA assembly methods have transformed from simple ‘cut-and-paste’ procedures to highly advanced, standardised assembly techniques. Implementing these standardised DNA assembly methods in biotechnological research conducted in non-model hosts, including Pseudomonas putida and Pseudomonas aeruginosa, could greatly benefit reproducibility and predictability of experimental results. SEVAtile is a Type IIs-based assembly approach, which enables the rapid and standardised assembly of genetic parts – or tiles – to create genetic circuits in the established SEVA-vector backbone. Contrary to existing DNA assembly methods, SEVAtile is an easy and straightforward method, which is compatible with any vector, both SEVA- and non-SEVA. To prove the efficiency of the SEVAtile method, a three-vector system was successfully generated to independently co-express three different proteins in P. putida and P. aeruginosa. More specifically, one of the vectors, pBGDes, enables genomic integration of assembled circuits in the Tn7 landing site, while self-replicatory vectors pSTDesX and pSTDesR enable inducible expression from the XylS/Pm and RhaRS/PrhaB expression systems, respectively. Together, we hope these vector systems will support research in both the microbial SynBio and Pseudomonas field.
{"title":"SEVAtile: a standardised DNA assembly method optimised for Pseudomonas","authors":"Eveline-Marie Lammens, Maarten Boon, Dennis Grimon, Yves Briers, Rob Lavigne","doi":"10.1111/1751-7915.13922","DOIUrl":"https://doi.org/10.1111/1751-7915.13922","url":null,"abstract":"<p>To meet the needs of synthetic biologists, DNA assembly methods have transformed from simple ‘cut-and-paste’ procedures to highly advanced, standardised assembly techniques. Implementing these standardised DNA assembly methods in biotechnological research conducted in non-model hosts, including <i>Pseudomonas putida</i> and <i>Pseudomonas aeruginosa</i>, could greatly benefit reproducibility and predictability of experimental results. SEVAtile is a Type IIs-based assembly approach, which enables the rapid and standardised assembly of genetic parts – or tiles – to create genetic circuits in the established SEVA-vector backbone. Contrary to existing DNA assembly methods, SEVAtile is an easy and straightforward method, which is compatible with any vector, both SEVA- and non-SEVA. To prove the efficiency of the SEVAtile method, a three-vector system was successfully generated to independently co-express three different proteins in <i>P. putida</i> and <i>P. aeruginosa</i>. More specifically, one of the vectors, pBGDes, enables genomic integration of assembled circuits in the Tn7 landing site, while self-replicatory vectors pSTDesX and pSTDesR enable inducible expression from the XylS/<i>Pm</i> and RhaRS/<i>PrhaB</i> expression systems, respectively. Together, we hope these vector systems will support research in both the microbial SynBio and <i>Pseudomonas</i> field.</p>","PeriodicalId":49145,"journal":{"name":"Microbial Biotechnology","volume":"15 1","pages":"370-386"},"PeriodicalIF":5.7,"publicationDate":"2021-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sfamjournals.onlinelibrary.wiley.com/doi/epdf/10.1111/1751-7915.13922","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"6238369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The alarming rise in the emergence of antimicrobial resistance in human, animal and plant pathogens is challenging global health and food production. Traditional strategies used for antibiotic discovery persistently result in the re-isolation of known compounds, calling for the need to develop more rational strategies to identify new antibiotics. Additionally, anti-infective therapy approaches targeting bacterial signalling pathways related to virulence is emerging as an alternative to the use of antibiotics. In this perspective article, we critically analyse approaches aimed at revitalizing the identification of new antibiotics and to advance antivirulence therapies. The development of high-throughput in vivo, in vitro and in silico platforms, together with the progress in chemical synthesis, analytical chemistry and structural biology, are reviving a research area that is of tremendous relevance for global health.
{"title":"Antimicrobial resistance: progress and challenges in antibiotic discovery and anti-infective therapy","authors":"Tino Krell, Miguel A. Matilla","doi":"10.1111/1751-7915.13945","DOIUrl":"https://doi.org/10.1111/1751-7915.13945","url":null,"abstract":"<p>The alarming rise in the emergence of antimicrobial resistance in human, animal and plant pathogens is challenging global health and food production. Traditional strategies used for antibiotic discovery persistently result in the re-isolation of known compounds, calling for the need to develop more rational strategies to identify new antibiotics. Additionally, anti-infective therapy approaches targeting bacterial signalling pathways related to virulence is emerging as an alternative to the use of antibiotics. In this perspective article, we critically analyse approaches aimed at revitalizing the identification of new antibiotics and to advance antivirulence therapies. The development of high-throughput <i>in vivo</i>, <i>in vitro</i> and <i>in silico</i> platforms, together with the progress in chemical synthesis, analytical chemistry and structural biology, are reviving a research area that is of tremendous relevance for global health.</p>","PeriodicalId":49145,"journal":{"name":"Microbial Biotechnology","volume":"15 1","pages":"70-78"},"PeriodicalIF":5.7,"publicationDate":"2021-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sfamjournals.onlinelibrary.wiley.com/doi/epdf/10.1111/1751-7915.13945","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"6094987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Living systems are studied using three complementary approaches: living cells, cell-free systems and computer-mediated modelling. Progresses in understanding, allowing researchers to create novel chassis and industrial processes rest on a cycle that combines in vivo, in vitro and in silico studies. This design–build–test–learn iteration loop cycle between experiments and analyses combines together physiology, genetics, biochemistry and bioinformatics in a way that keeps going forward. Because computer-aided approaches are not directly constrained by the material nature of the entities of interest, we illustrate here how this virtuous cycle allows researchers to explore chemistry which is foreign to that present in extant life, from whole chassis to novel metabolic cycles. Particular emphasis is placed on the importance of evolution.
{"title":"In vivo, in vitro and in silico: an open space for the development of microbe-based applications of synthetic biology","authors":"Antoine Danchin","doi":"10.1111/1751-7915.13937","DOIUrl":"https://doi.org/10.1111/1751-7915.13937","url":null,"abstract":"<p>Living systems are studied using three complementary approaches: living cells, cell-free systems and computer-mediated modelling. Progresses in understanding, allowing researchers to create novel chassis and industrial processes rest on a cycle that combines <i>in vivo</i>, <i>in vitro</i> and <i>in silico</i> studies. This design–build–test–learn iteration loop cycle between experiments and analyses combines together physiology, genetics, biochemistry and bioinformatics in a way that keeps going forward. Because computer-aided approaches are not directly constrained by the material nature of the entities of interest, we illustrate here how this virtuous cycle allows researchers to explore chemistry which is foreign to that present in extant life, from whole chassis to novel metabolic cycles. Particular emphasis is placed on the importance of evolution.</p>","PeriodicalId":49145,"journal":{"name":"Microbial Biotechnology","volume":"15 1","pages":"42-64"},"PeriodicalIF":5.7,"publicationDate":"2021-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sfamjournals.onlinelibrary.wiley.com/doi/epdf/10.1111/1751-7915.13937","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"6076578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Amino acids have traditionally been derived on scale via microbes that overproduce specific amino acids that they excrete into fermentation broths. This paper describes the potential to use biomass and specific catalysts to produce a number of a-amino acids. If scalable and economically feasible, these methods could compete with the current microbial fermentation processes used in industry. Microbial Biotechnology (2021) 14(5), 2241–2242 doi:10.1111/1751-7915.13923
{"title":"Web Alert: Amino acids from microbes for biotechnology","authors":"Lawrence P. Wackett","doi":"10.1111/1751-7915.13923","DOIUrl":"https://doi.org/10.1111/1751-7915.13923","url":null,"abstract":"Amino acids have traditionally been derived on scale via microbes that overproduce specific amino acids that they excrete into fermentation broths. This paper describes the potential to use biomass and specific catalysts to produce a number of a-amino acids. If scalable and economically feasible, these methods could compete with the current microbial fermentation processes used in industry. Microbial Biotechnology (2021) 14(5), 2241–2242 doi:10.1111/1751-7915.13923","PeriodicalId":49145,"journal":{"name":"Microbial Biotechnology","volume":"14 5","pages":"2241-2242"},"PeriodicalIF":5.7,"publicationDate":"2021-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sfamjournals.onlinelibrary.wiley.com/doi/epdf/10.1111/1751-7915.13923","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"5696680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Steroidal oestrogens (C18) are contaminants receiving increasing attention due to their endocrine-disrupting activities at sub-nanomolar concentrations. Although oestrogens can be eliminated through photodegradation, microbial function is critical for removing oestrogens from ecosystems devoid of sunlight exposure including activated sludge, soils and aquatic sediments. Actinobacteria were found to be key oestrogen degraders in manure-contaminated soils and estuarine sediments. Previously, we used the actinobacterium Rhodococcus sp. strain B50 as a model microorganism to identify two oxygenase genes, aedA and aedB, involved in the activation and subsequent cleavage of the estrogenic A-ring respectively. However, genes responsible for the downstream degradation of oestrogen A/B-rings remained completely unknown. In this study, we employed tiered comparative transcriptomics, gene disruption experiments and mass spectrometry-based metabolite profile analysis to identify oestrogen catabolic genes. We observed the up-regulation of thiolase-encoding aedF and aedK in the transcriptome of strain B50 grown with oestrone. Consistently, two downstream oestrogenic metabolites, 5-oxo-4-norestrogenic acid (C17) and 2,3,4-trinorestrogenic acid (C15), were accumulated in aedF- and aedK-disrupted strain B50 cultures. Disruption of fadD3 [3aα-H-4α(3'-propanoate)-7aβ-methylhexahydro-1,5-indanedione (HIP)-coenzyme A-ligase gene] in strain B50 resulted in apparent HIP accumulation in oestrone-fed cultures, indicating the essential role of fadD3 in actinobacterial oestrogen degradation. In addition, we detected a unique meta-cleavage product, 4,5-seco-estrogenic acid (C18), during actinobacterial oestrogen degradation. Differentiating the oestrogenic metabolite profile and degradation genes of actinobacteria and proteobacteria enables the cost-effective and time-saving identification of potential oestrogen degraders in various ecosystems through liquid chromatography–mass spectrometry analysis and polymerase chain reaction-based functional assays.
{"title":"Identification of essential β-oxidation genes and corresponding metabolites for oestrogen degradation by actinobacteria","authors":"Tsun-Hsien Hsiao, Tzong-Huei Lee, Meng-Rong Chuang, Po-Hsiang Wang, Menghsiao Meng, Masae Horinouchi, Toshiaki Hayashi, Yi-Lung Chen, Yin-Ru Chiang","doi":"10.1111/1751-7915.13921","DOIUrl":"https://doi.org/10.1111/1751-7915.13921","url":null,"abstract":"<p>Steroidal oestrogens (C<sub>18</sub>) are contaminants receiving increasing attention due to their endocrine-disrupting activities at sub-nanomolar concentrations. Although oestrogens can be eliminated through photodegradation, microbial function is critical for removing oestrogens from ecosystems devoid of sunlight exposure including activated sludge, soils and aquatic sediments. Actinobacteria were found to be key oestrogen degraders in manure-contaminated soils and estuarine sediments. Previously, we used the actinobacterium <i>Rhodococcus</i> sp. strain B50 as a model microorganism to identify two oxygenase genes, <i>aedA</i> and <i>aedB</i>, involved in the activation and subsequent cleavage of the estrogenic A-ring respectively. However, genes responsible for the downstream degradation of oestrogen A/B-rings remained completely unknown. In this study, we employed tiered comparative transcriptomics, gene disruption experiments and mass spectrometry-based metabolite profile analysis to identify oestrogen catabolic genes. We observed the up-regulation of thiolase-encoding <i>aedF</i> and <i>aedK</i> in the transcriptome of strain B50 grown with oestrone. Consistently, two downstream oestrogenic metabolites, 5-oxo-4-norestrogenic acid (C<sub>17</sub>) and 2,3,4-trinorestrogenic acid (C<sub>15</sub>), were accumulated in <i>aedF-</i> and <i>aedK</i>-disrupted strain B50 cultures. Disruption of <i>fadD3</i> [3aα-H-4α(3'-propanoate)-7aβ-methylhexahydro-1,5-indanedione (HIP)-coenzyme A-ligase gene] in strain B50 resulted in apparent HIP accumulation in oestrone-fed cultures, indicating the essential role of <i>fadD3</i> in actinobacterial oestrogen degradation. In addition, we detected a unique <i>meta</i>-cleavage product, 4,5-<i>seco</i>-estrogenic acid (C<sub>18</sub>), during actinobacterial oestrogen degradation. Differentiating the oestrogenic metabolite profile and degradation genes of actinobacteria and proteobacteria enables the cost-effective and time-saving identification of potential oestrogen degraders in various ecosystems through liquid chromatography–mass spectrometry analysis and polymerase chain reaction-based functional assays.</p>","PeriodicalId":49145,"journal":{"name":"Microbial Biotechnology","volume":"15 3","pages":"949-966"},"PeriodicalIF":5.7,"publicationDate":"2021-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/1751-7915.13921","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"5677613","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Irfan Farabi Hayat, Manuel Plan, Birgitta E. Ebert, Geoff Dumsday, Claudia E. Vickers, Bingyin Peng
The yeast Saccharomyces cerevisiae uses the pyruvate dehydrogenase-bypass for acetyl-CoA biosynthesis. This relatively inefficient pathway limits production potential for acetyl-CoA-derived biochemical due to carbon loss and the cost of two high-energy phosphate bonds per molecule of acetyl-CoA. Here, we attempted to improve acetyl-CoA production efficiency by introducing heterologous acetylating aldehyde dehydrogenase and phosphoketolase pathways for acetyl-CoA synthesis to enhance production of the sesquiterpene trans-nerolidol. In addition, we introduced auxin-mediated degradation of the glucose-dependent repressor Mig1p to allow induced expression of GAL promoters on glucose so that production potential on glucose could be examined. The novel genes that we used to reconstruct the heterologous acetyl-CoA pathways did not sufficiently complement the loss of endogenous acetyl-CoA pathways, indicating that superior heterologous enzymes are necessary to establish fully functional synthetic acetyl-CoA pathways and properly explore their potential for nerolidol synthesis. Notwithstanding this, nerolidol production was improved twofold to a titre of ˜ 900 mg l−1 in flask cultivation using a combination of heterologous acetyl-CoA pathways and Mig1p degradation. Conditional Mig1p depletion is presented as a valuable strategy to improve the productivities in the strains engineered with GAL promoters-controlled pathways when growing on glucose.
{"title":"Auxin-mediated induction of GAL promoters by conditional degradation of Mig1p improves sesquiterpene production in Saccharomyces cerevisiae with engineered acetyl-CoA synthesis","authors":"Irfan Farabi Hayat, Manuel Plan, Birgitta E. Ebert, Geoff Dumsday, Claudia E. Vickers, Bingyin Peng","doi":"10.1111/1751-7915.13880","DOIUrl":"https://doi.org/10.1111/1751-7915.13880","url":null,"abstract":"<p>The yeast <i>Saccharomyces cerevisiae</i> uses the pyruvate dehydrogenase-bypass for acetyl-CoA biosynthesis. This relatively inefficient pathway limits production potential for acetyl-CoA-derived biochemical due to carbon loss and the cost of two high-energy phosphate bonds per molecule of acetyl-CoA. Here, we attempted to improve acetyl-CoA production efficiency by introducing heterologous acetylating aldehyde dehydrogenase and phosphoketolase pathways for acetyl-CoA synthesis to enhance production of the sesquiterpene <i>trans</i>-nerolidol. In addition, we introduced auxin-mediated degradation of the glucose-dependent repressor Mig1p to allow induced expression of <i>GAL</i> promoters on glucose so that production potential on glucose could be examined. The novel genes that we used to reconstruct the heterologous acetyl-CoA pathways did not sufficiently complement the loss of endogenous acetyl-CoA pathways, indicating that superior heterologous enzymes are necessary to establish fully functional synthetic acetyl-CoA pathways and properly explore their potential for nerolidol synthesis. Notwithstanding this, nerolidol production was improved twofold to a titre of ˜ 900 mg l<sup>−1</sup> in flask cultivation using a combination of heterologous acetyl-CoA pathways and Mig1p degradation. Conditional Mig1p depletion is presented as a valuable strategy to improve the productivities in the strains engineered with <i>GAL</i> promoters-controlled pathways when growing on glucose.</p>","PeriodicalId":49145,"journal":{"name":"Microbial Biotechnology","volume":"14 6","pages":"2627-2642"},"PeriodicalIF":5.7,"publicationDate":"2021-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/1751-7915.13880","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"5783054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Maciej W. Guzik, Gearóid F. Duane, Shane T. Kenny, Eoin Casey, Pawe? Mielcarek, Magdalena Wojnarowska, Kevin E. O’Connor
The modelling and optimization of a process for the production of the medium chain length polyhydroxyalkanoate (mcl-PHA) by the bacterium Pseudomonas putida KT2440 when fed a synthetic fatty acid mixture (SFAM) was investigated. Four novel feeding strategies were developed and tested using a constructed model and the optimum one implemented in further experiments. This strategy yielded a cell dry weight of 70.6 g l−1 in 25 h containing 38% PHA using SFAM at 5 l scale. A phosphate starvation strategy was implemented to improve PHA content, and this yielded 94.1 g l−1 in 25 h containing 56% PHA using SFAM at 5 l scale. The process was successfully operated at 20 l resulting in a cell dry weight of 91.2 g l−1 containing 65% PHA at the end of a 25-h incubation.
研究了恶臭假单胞菌KT2440在合成脂肪酸混合物(sfm)条件下生产中链长聚羟基烷酸酯(mcl-PHA)的工艺模型和优化。采用构建的模型对四种新的喂养策略进行了测试,并在进一步的实验中实施了最优喂养策略。该策略在25小时内产生了70.6 g l−1的细胞干重,其中含有38%的PHA。采用磷酸盐饥饿策略来提高PHA含量,在5 l的sfm中,25 h的产量为94.1 g l−1,PHA含量为56%。该工艺在20 l条件下成功操作,在25 h孵育结束时,细胞干重为91.2 g l−1,含65% PHA。
{"title":"A polyhydroxyalkanoates bioprocess improvement case study based on four fed-batch feeding strategies","authors":"Maciej W. Guzik, Gearóid F. Duane, Shane T. Kenny, Eoin Casey, Pawe? Mielcarek, Magdalena Wojnarowska, Kevin E. O’Connor","doi":"10.1111/1751-7915.13879","DOIUrl":"https://doi.org/10.1111/1751-7915.13879","url":null,"abstract":"<p>The modelling and optimization of a process for the production of the medium chain length polyhydroxyalkanoate (mcl-PHA) by the bacterium <i>Pseudomonas putida</i> KT2440 when fed a synthetic fatty acid mixture (SFAM) was investigated. Four novel feeding strategies were developed and tested using a constructed model and the optimum one implemented in further experiments. This strategy yielded a cell dry weight of 70.6 g l<sup>−1</sup> in 25 h containing 38% PHA using SFAM at 5 l scale. A phosphate starvation strategy was implemented to improve PHA content, and this yielded 94.1 g l<sup>−1</sup> in 25 h containing 56% PHA using SFAM at 5 l scale. The process was successfully operated at 20 l resulting in a cell dry weight of 91.2 g l<sup>−1</sup> containing 65% PHA at the end of a 25-h incubation.</p>","PeriodicalId":49145,"journal":{"name":"Microbial Biotechnology","volume":"15 3","pages":"996-1006"},"PeriodicalIF":5.7,"publicationDate":"2021-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/1751-7915.13879","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"5783049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}